The sixth Asia Summit on Global Health (ASGH) and the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair) concluded successfully, drawing thousands of participants and facilitating over 1,000 business matching meetings, according to organizers. The events, held during International Healthcare Week, underscored Hong Kong's role as a superconnector for global healthcare innovation and investment.
The ASGH, jointly organized by the Government of the Hong Kong Special Administrative Region and the Hong Kong Trade Development Council (HKTDC), gathered some 3,000 participants from 43 countries and regions. The summit featured over 90 global leaders, including Nobel laureates and industry executives, who discussed topics such as pandemic preparedness, AI in healthcare, and the silver health economy. More than 400 one-on-one deal-making meetings were arranged, and several Memoranda of Understanding (MoUs) were signed, including between HKSH Medical Group and Siemens Healthineers, making HKSH Siemens Healthineers' first Photon Counting Computed Tomography Simulation Reference Site in Asia. Another MoU was signed between HKTDC and the Hong Kong Singapore Business Association to support Mainland enterprises' expansion into ASEAN markets.
The concurrent Medical Fair, organized by HKTDC and co-organized by the Hong Kong MedTech Association, welcomed some 13,000 buyers from 61 countries and regions. Over 670 business matching meetings were held, supporting exhibitors in finding partners. The fair featured around 300 exhibitors from 10 countries, focusing on MedTech, GeronTech, and preventive healthcare. Exhibitors reported strong interest in AI-powered solutions, with some signing deals worth over HK$1 million. For example, Dresio Limited, a Hong Kong-based startup, signed an MoU with a Filipino buyer on the third day to expand its contactless physiotherapy assessment system into Southeast Asia.
The events highlighted the growing importance of AI in healthcare. Natasha Chhatrapati, Senior Director at Pfizer, noted that AI is compressing timelines across drug development and patient care. Dr. James Xue of CANbridge Pharmaceuticals emphasized China's advantage due to its large population for building better drug candidates. The silver health sector also received attention, with Dr. Alex Mihailidis of the University of Toronto stressing that successful technology for older adults requires not just the tech but also service delivery models and policy support.
The ASGH also facilitated cross-border collaborations. Colin Tan of TusPark Holdings brought 15 UK healthcare companies to the UK Pavilion and is now facilitating a cancer research partnership between a UK organization and a Hong Kong counterpart. Australian startup SDIP Innovations, returning for a second year, credited last year's visit with securing an IGNITE grant from HSITP. The events provided a platform for companies to explore Asian markets and gain international credibility.
The Medical Fair hosted over 50 forums and seminars, with topics including mental health innovation, ASEAN regulations, and gerontechnology. Exhibitors and buyers praised the fair for its networking opportunities. Dr. Keo Sovann from Cambodia's Orchid Hospital found potential suppliers for AI-powered medical imaging, while a Moroccan buyer from Promamec engaged in discussions for thermodynamics solutions. The hybrid EXHIBITION+ model allowed continued networking via Click2Match until May 20.
Overall, the ASGH and Medical Fair demonstrated strong synergy between medical technology, investment, and industry applications, reinforcing Hong Kong's position as a global healthcare hub. The events not only facilitated immediate business deals but also laid groundwork for long-term collaborations in AI, silver health, and international expansion.
